177 related articles for article (PubMed ID: 16150648)
41. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease.
Kim EY; Hong YB; Lai Z; Kim HJ; Cho YH; Brady RO; Jung SC
Biochem Biophys Res Commun; 2004 May; 318(2):381-90. PubMed ID: 15120612
[TBL] [Abstract][Full Text] [Related]
42. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
43. Using lentiviral vectors for efficient pancreatic cancer gene therapy.
Ravet E; Lulka H; Gross F; Casteilla L; Buscail L; Cordelier P
Cancer Gene Ther; 2010 May; 17(5):315-24. PubMed ID: 19911032
[TBL] [Abstract][Full Text] [Related]
44. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
[TBL] [Abstract][Full Text] [Related]
45. HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.
Zeng L; Planelles V; Sui Z; Gartner S; Maggirwar SB; Dewhurst S; Ye L; Nerurkar VR; Yanagihara R; Lu Y
J Gene Med; 2006 Jan; 8(1):18-28. PubMed ID: 16142830
[TBL] [Abstract][Full Text] [Related]
46. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
47. Short-term culture of human CD34+ cells for lentiviral gene transfer.
Santoni de Sio F; Naldini L
Methods Mol Biol; 2009; 506():59-70. PubMed ID: 19110619
[TBL] [Abstract][Full Text] [Related]
48. Efficient gene transfer into human monocyte-derived macrophages using defective lentiviral vectors.
Lu Y; Liu C; Zeng L; Lin Z; Dewhurst S; Gartner S; Planelles V
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1151-6. PubMed ID: 14682398
[TBL] [Abstract][Full Text] [Related]
49. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.
Xu K; Ma H; McCown TJ; Verma IM; Kafri T
Mol Ther; 2001 Jan; 3(1):97-104. PubMed ID: 11162316
[TBL] [Abstract][Full Text] [Related]
50. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].
Ma XS; Jiang JY; Lü FZ; Ma X; Li XK; Huang HY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3340-4. PubMed ID: 17313830
[TBL] [Abstract][Full Text] [Related]
51. Generation of lentivirus vectors using recombinant baculoviruses.
Lesch HP; Turpeinen S; Niskanen EA; Mähönen AJ; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2008 Sep; 15(18):1280-6. PubMed ID: 18463689
[TBL] [Abstract][Full Text] [Related]
52. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
53. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
Gropp M; Reubinoff B
Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
[TBL] [Abstract][Full Text] [Related]
54. Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex.
Shimizu S; Urano E; Futahashi Y; Miyauchi K; Isogai M; Matsuda Z; Nohtomi K; Onogi T; Takebe Y; Yamamoto N; Komano J
AIDS; 2007 Mar; 21(5):575-82. PubMed ID: 17314519
[TBL] [Abstract][Full Text] [Related]
55. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
Kremer KL; Dunning KR; Parsons DW; Anson DS
J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
[TBL] [Abstract][Full Text] [Related]
56. Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy.
Vargas J; Klotman ME; Cara A
Antiviral Res; 2008 Dec; 80(3):288-94. PubMed ID: 18647620
[TBL] [Abstract][Full Text] [Related]
57. Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope.
Morizono K; Ringpis GE; Pariente N; Xie Y; Chen IS
Virology; 2006 Nov; 355(1):71-81. PubMed ID: 16905172
[TBL] [Abstract][Full Text] [Related]
58. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K
Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115
[TBL] [Abstract][Full Text] [Related]
59. Stable gene transfer to the nervous system using a non-primate lentiviral vector.
Mitrophanous K; Yoon S; Rohll J; Patil D; Wilkes F; Kim V; Kingsman S; Kingsman A; Mazarakis N
Gene Ther; 1999 Nov; 6(11):1808-18. PubMed ID: 10602376
[TBL] [Abstract][Full Text] [Related]
60. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
Wingard JB; Anderson B; Weissman D
Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
